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Abstract 
 
The oral group treatment is still a common procedure in swine production. This project 
studied the effect of the application of 3 different formulations of antimicrobial premixes 
(1. chlortetracycline, 2. chlortetracycline + sulfadimidine + tylosin, 3. sulfadimidine + 
sulfathiazole + trimethoprim) via the liquid feeding system on the occurrence of 
tetracycline-resistant Enterobacteriaceae (Ent-Tetr) in the liquid feed. 156 and 112 feed 
samples were collected between April and December 2015 in 13 case and 14 control farms, 
respectively. The 27 farms were randomly selected pig fattening farms located in different 
parts of Switzerland. The number of feed samples that contained Ent-Tetr as well as the 
number of Enterobacteriaceae resistant to tetracycline per sample was significantly higher 
in the case group than in the control group. The use of any of the 3 antimicrobial 
combinations turned out to be the main risk factor for the occurrence of Ent-Tetr in the 
liquid feed. Our results suggest that liquid feed containing antimicrobials is a reservoir of 
antimicrobial resistant bacteria in swine production. 
 
Keywords: antimicrobial resistance, oral group therapy, tetracycline, Enterobacteriaceae, 
liquid feeding, fattening pigs 
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Zusammenfassung 
 
Die orale Gruppentherapie ist eine immer noch verbreitete Managementmassnahme in der 
Schweineproduktion. Diese Arbeit untersuchte den Effekt der Applikation von 3 
verschiedenen Formulierungen antibiotikahaltiger Arzneimittelvormischungen (1. 
Chlortetrazyklin, 2. Chlortetrazyklin + Sulfadimidin + Tylosin, 3. Sulfadimidin + 
Sulfathiazol + Trimethoprim) über die Flüssigfütterungsanlage auf das Vorkommen 
Tetrazyklin-resistenter Enterobacteraiaceae (Ent-Tetr) im Flüssigfutter. 156 bzw. 112 
Futterproben wurden zwischen April und Dezember 2015 auf 13 Fall- bzw. 14 
Kontrollbetrieben erhoben. Bei den 27 Betrieben handelte es sich um zufällig ausgewählte 
Schweinemastbetriebe aus verschiedenen Regionen der Schweiz. Die Anzahl Futterproben, 
die Tetrazyklin-resistente Enterobacteriaceae enthielten, sowie die Keimzahl Ent-Tetr pro 
Futterprobe waren signifikant höher in der Fall- als in der Kontrollgruppe. Der Einsatz der 
untersuchten Formulierungen von Arzneimittelvormischungen konnte als Hauptrisikofaktor 
für das Auftreten von Ent-Tetr im Flüssigfutter identifiziert werden. Die Ergebnisse legen 
nahe, dass antibiotikahaltiges Flüssigfutter ein Reservoir für Antibiotika-resistente 
Bakterien in der Schweineproduktion darstellt. 
 
Schlüsselwörter: Antibiotikaresistenz, orale Gruppentherapie, Tetrazyklin, 
Enterobacteriaceae, Flüssigfütterung, Mastschweine 
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Introduction 
 
The annual amount of antimicrobials used for farm animals in Switzerland has 
continuously decreased from 71’316 kg in 2008 to 48’402 kg in 2014 (-32.1%) (ARCH-
VET, 2014). In 2014, antimicrobial premixes (AMP) intended for adding to animal feed 
made up 60% of the total amount of antimicrobials used in farm animals. The amounts of 
antimicrobials presented in the ARCH-VET report (2014) are, however, not discriminated 
by animal species, age group and indication. A study conducted by Regula et al. (2009) on 
the prescription patterns in 8 veterinary practices in Switzerland found that 39% and 14% 
of the total amount of 1’590 kg of antimicrobials were prescribed for pigs and pigs or 
cattle, respectively. Under the assumption that this finding is representative for whole of 
Switzerland, the amount of AMP prescribed for pigs can be extrapolated to at least 11’326 
kg or 23.4% of the total amount of antimicrobials used for farm animals in 2014. The 
treatment, prevention and control of bacterial diseases in pigs are often accomplished by 
oral antimicrobial group treatment, thus explaining the considerable proportion of 
antimicrobials used as feed additive in pigs. According to Müntener et al. (2013), piglets 
after weaning and fattening pigs after arrival in the fattening farm are the two age groups 
that are most frequently treated with antimicrobials. Riklin (2015) studied the antimicrobial 
use and the associated risk factors during the fattening period in 101 pig fattening farms in 
Switzerland and identified, based on the animal treatment index defined by Blaha et al. 
(2006), the prophylactic oral group treatment as the main indication (79%) for 
antimicrobial use in the fattening period. The treatment of various diseases by oral group 
treatment (18%) and individual parenteral treatment (3%) were distinctly less significant 
indications for using antimicrobials in fattening pigs. The most used AMPs for oral group 
treatments was a combination of sulfathiazole, sulfadimidine and trimethoprim, being 
followed by a triple combination containing chlortetracycline, sulfadimidine and tylosin 
and AMPs containing only chlortetracycline and colistin, respectively. 
The antimicrobial oral group treatment can be performed by feeding a medicated feed 
mixed by the farmer himself, by adding the AMP into the mixing tank of a liquid feeding 
system, by mixing the feed and AMP directly in the trough (top dressing) or by feeding a 
medicated feed mixed by a feed mill. Liquid feeding is the main feeding system used in 
Swiss pig fattening farms. There are different construction types of liquid feeding systems, 
the easiest one consisting of a mixing tank, a feed scale under the mixing tank, a pump that 
pumps the liquid feed from the mixing tank trough the circuit pipeline to the drop lines 
which direct the liquid feed to the feed troughs. The feeding process is controlled by a 
computer that triggers the two unidirectional valves at the start and the end of the circuit 
pipeline and the dosing valves at the junctions connecting the circuit pipeline and the drop 
lines. In a liquid feeding system of this type, the liquid feed inside the circuit pipeline 
remains there between two feeding times, being diluted with water in some farms, and is 
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pumped back into the mixing tank during the mixing process. The drop lines are completely 
or partially free of feed between feeding times depending on the slope of the correspondent 
segments. 
The liquid feeding systems are coated with a biofilm consisting, apart from water and 
bacteria, of different types of extracellular polymeric substances such as 
exopolysaccharides, proteins, nucleic acids and lipids (Flemming and Wingender, 2010). 
Antimicrobials are not only hindered by the biofilm matrix in their action against the 
microorganisms embedded in it, they may also induce the formation of biofilms dependant 
on the bacterial species and the antimicrobial concentration (Kaplan, 2011; Costa et al., 
2012). The application of antimicrobials over a liquid feeding system therefore poses a risk 
of selecting antimicrobial resistant bacteria (ARB) in the biofilm by locally sub-inhibitory 
antimicrobial concentrations and the favourable conditions in the biofilm matrix for 
horizontal gene transfer (HGT) (Flemming and Wingender, 2010). The biofilm coating of a 
liquid feeding system may therefore ultimately be regarded as a reservoir of ARB, which 
can be detached and dispersed from the biofilm by mechanical forces or various biological 
processes at any time (Karatan and Watnick, 2009) and which are subsequently ingested by 
the pigs, thus adding further antimicrobial resistance (AMR) genes to the AMR gene pool 
already present in the pig gut. The administration of antimicrobials in pig fattening farms 
via “farm specific equipments”, which are mainly liquid feeding systems, accounted still 
for 20% of the chosen application method in a study conducted by Müntener et al. (2013). 
The commonly used antimicrobials in the AMPs sold in Switzerland for the use in 
prophylactic oral group treatment of fattening pigs are tetracycline and sulphonamide. The 
aim of this case-control-study was to quantitatively assess the effect of the administration 
of three different AMP formulations via the liquid feeding system on the occurrence of 
Enterobacteriaceae resistant to tetracycline (Ent-Tetr) in the liquid feed for pigs. 
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Material and Methods 
 
Study design  
 
For this case-control-study, 268 feed samples were collected between April and December 
2015 at 27 pig fattening farms located in different areas of Switzerland. All farms used a 
computer-assisted liquid feeding system with water or whey as liquid phase. They all fed 
non-fermented liquid feed meaning that the conventional dry compound feed and the liquid 
were mixed immediately before feeding. The control group, encompassing 14 farms, was 
defined as farms that have not added any antimicrobials to the liquid feed for at least 2 
years. The case group comprised 13 farms that administered AMP via the liquid feed in 
every fattening period of the last 2 years. Three different AMP formulations were used: 
chlortetracycline alone (3 farms, 23.1%), a combination of sulfadimidine, sulfathiazole and 
trimethoprim (7 farms, 53.8%) or a combination of chlortetracycline, sulfadimidine and 
tylosin (3 farms, 23.1%) (Tab. 1). The farms’ individual routines applied for cleaning the 
liquid feeding system were not altered during the study. This approach allows for 
estimating the influence of the various management routines on the number of resistant 
isolates in the liquid feed. Table 2 summarises the cleaning interval, the cleaning procedure 
and the agents used for cleaning the circuit pipeline of the liquid feeding system. 
 
Sample collection 
 
Samples were collected at 4 time points in control and at 6 time points in case farms. In 
control farms, the second, third and fourth sample time were fixed on day 6, 12 and 78 after 
the collection of the first 2 samples. In case farms, the sampling started shortly after the 
entry of the pigs in the fattening unit but still before the medication. The remaining 5 
sampling time points were scheduled on day 6, 12, 18, 36 and 76 after the start of the 
antimicrobial group treatment. The second sampling point was during medication in every 
case. At each time point, 2 samples were taken at 2 different locations, namely at the end of 
the circuit pipeline, which is situated right over the mixing tank, and at the end of the drop 
line that is the last one breaching off the circuit pipeline before its end. The feed samples 
were directly collected from either tube by holding a sterile container in the outflowing 
liquid feed without touching anything from the surroundings. As the liquid feed in all the 
investigated farms remains in the circuit pipeline between the feeding times, all the 
sampling was done at the morning feeding thus ensuring to collect samples from liquid feed 
that had interacted with the biofilm coating the inside of the tubes during the longest time 
period between two feeding times (10.5 – 15.75 hours). 
Every farmer was interviewed about the use of antimicrobials, the construction and 
functioning of the liquid feeding system, the sanitary status of his farm, the type of feed and 
liquid phase, any potential acidification of the liquid feed and the different routines applied 
for cleaning the circuit pipeline, the drop lines, the mixing tank, the fodder silo and the 
whey tank, if there is any. 
 
Microbiological analysis 
 
All feed samples were kept cool during transport and were processed immediately upon 
arrival in the laboratory. The pH value of each sample was determined using a pH meter 
(Orion 525, Hügli, Abtwil). The quantitative assessment of the number of 
Enterobacteriaceae and Ent-Tetr was performed by means of 2 serial dilutions with a 
detection limit of 10 colony forming units/ml (cfu/ml) each. MacConkey agar (Oxoid, 
Hampshire, UK) and MacConkey agar supplemented with 8 mg/ml tetracycline (Sigma-
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Aldrich, St. Louis, USA) were used for the detection of Enterobacteriaceae and Ent-Tetr, 
respectively. The MacConkey agar plates were incubated anaerobically during 24 h at 37° 
C. After the incubation, the colonies were counted and 1 colony of each morphological 
distinct resistant colony was subcultered using again a MacConkey agar supplemented with 
8 mg/ml tetracycline and incubated anaerobically during 24 h at 37° C. This approach 
allows for the confirmation of resistance of the isolated colony. 
In addition to the quantitative assessment of Ent-Tetr, the first 2 samples of every case farm 
and the last 2 samples of every control farm were enriched for Enterobacteriaceae using 10 
ml of liquid feed and 90 ml of Enterobacteriaceae Enrichment (EE) broth (BD, Franklin 
Lakes, USA) and subcultured on MacConkey agar supplemented with 8 mg/ml tetracycline. 
This qualitative assessment allows for the detection of resistant Enterobacteriaceae in case 
the number of the same is less than the detection limit of 10 cfu/ml. Furthermore, this 
approach allows for determining whether or not there were Ent-Tetr even before the 
antimicrobial group treatment.  
 
Statistical analysis 
 
Data were analysed using the commercial statistical software Stata (StataCorp. 2011. Stata 
Statistical Software: Release 12. College Station, TX: StataCorp LP). The number of 
Enterobacteriaceae and Enterobacteriaceae resistant to tetracycline represented the 
dependent variables (observations) and were initially analysed by means of descriptive 
statistics. The independent variables were defined as group affiliation (case/control group), 
sample location (drop line = sampling site 1/circuit pipeline = sampling site 2), sample time 
(case group: t1,…,t6; control group t1,…,t4), type of AMP (AMP containing 
chlortetracycline/AMP containing only chlortetracycline), type of liquid phase 
(water/whey), cleaning of the circuit pipeline after the antimicrobial group treatment 
(yes/no), acidification of the liquid feed (yes/no). Each farm was assigned either to the case 
group or the control group. Therefore there was no clustering of farms when comparing the 
different sampling sites. Test for normality distribution was performed using the Shapiro–
Wilk test with the significance level of 95% (p-value ≤ 5%). As all data were not normally 
distributed and no transformation showed sufficient Gaussian distribution, the initial 
comparison between independent variables was performed using non-parametric tests, i.e. 
the Wilcoxon rank-sum test (Mann-Whitney U test) in case of two independent groups and 
the Kruskal-Wallis test in case of more than two groups. A general linear model was 
calculated (STATA command <by varx1, sort : xtmixed vary varx2 vart || vart>; varx1 = 
sample location, varx2 = group affiliation, vary = number of Ent-Tetr per sample, vart = 
time). Multiple non-parametric comparisons between several groups, e.g. observations at 
different sample times, were done with Dunn’s test of multiple comparisons using rank 
sums with Bonferroni adjustment. With all three tests, the significance level was chosen to 
be 95% (p-value ≤ 5%). In order to identify risk factors for the occurrence of Ent-Tetr in 
the liquid feed, the results of the univariate logistic regression models were used to define a 
full logistic regression model with random effects (STATA command <xtset vart>, <xtlogit 
vary varx vart>; varx = list of independent variables, vary = tetracycline resistance 
(dichotomous), vart = time). The univariate analysis was performed with 6 time points in 
case farms and with 4 time points in control farms. The multivariate analysis, however, was 
based only on the 4 time points which existed in both groups. The cut-off value for the 
dichotomous dependent variable tetracycline resistance corresponded with the detection 
limit of 10 cfu/ml for Ent-Tetr. The selection of the final risk factors was done by backward 
elimination so that the p-value of every risk factor was less than or equal to 0.05. 
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Results 
 
Enterobacteriaceae could be isolated from 119 (76.3%) samples of the case group and from 
63 (56.3%) samples of the control group (Tab. 3). In the case group, 68 (87.2%) samples 
collected at sampling site 1 and 51 samples (65.4%) collected at sampling site 2 contained 
Enterobacteriaceae. The corresponding values for the control group were 35 (62.5%) 
samples at sampling site 1 and 28 (50%) samples at sampling site 2, respectively. 
Tetracycline-resistant Enterobacteriaceae could be isolated from 104 (66.7%) samples of 
the case group and 7 (6.3%) samples of the control group. In the case group, 61 (78.2%) 
samples collected at sampling site 1 and 43 (55.1%) samples collected at sampling site 2 
contained Ent-Tetr. The corresponding values for the control group were 7 (12.5%) at 
sampling site 1 and 0 (0%) at sampling site 2, respectively. 
There was no case farm where the number of Ent-Tetr in all 6 samples at sampling site 1 
was below the detection limit of 10 cfu/ml (Tab. 4). However, there were 2 case farms 
where all 6 samples collected at sampling site 2 were below the detection limit of 10 cfu/ml 
for Ent-Tetr. Nonetheless, Ent-Tetr could be isolated in the samples of these two latter case 
farms taken at the first sample time and at sampling site 2 after an enrichment for 
Enterobacteriaceae had been performed. In summary, Ent-Tetr could be isolated in all case 
farms at both sampling sites by either using a quantitative or qualitative approach. 
Furthermore, all samples (100%) at sampling site 1 and all but 1 (92.3%, case farm 7) 
samples at sampling site 2, collected before the antimicrobial group treatment, contained 
Enterobacteriaceae resistant to tetracycline. 
 
There were 9 (64.3%) and 14 (100%) control farms, respectively, where the number of Ent-
Tetr was below the detection limit of 10 cfu/ml in all 4 samples at sampling sites 1 and 2, 
respectively (Tab. 4). The enrichment for Enterobacteriaceae revealed that the control 
farms 3 and 4 (14.3%) were free of Ent-Tetr at both sampling sites, whereas control farms 
5, 6, 8, 9, 10 and 12 (42.9%) were free only at sampling site 2. The control farms 1, 2, 7, 
11, 12 and 14 (42.9%) were positive at both sampling sites in the qualitative approach. In 
summary, there were 2 (14.3%) and 6 (42.9%) control farms, which were negative for Ent-
Tetr at sampling sites 1 + 2 or sampling site 2 only, respectively, using either a qualitative 
or a quantitative approach. 
 
The number of Ent-Tetr was higher in the case group than in the control group at sampling 
sites 1 + 2 (p < 0.0001), at sampling site 1 (p < 0.0001) and at sampling site 2 (p < 0.0001) 
(Tab. 3, Fig. 1). The number of Ent-Tetr differed significantly between the sample times in 
the case group at sampling sites 1 + 2 (p = 0.0401) (Fig. 2) and at sampling site 1 (p = 
0.0242), but not in the control group (p = 0.6860). The relative frequency of the number of 
Ent-Tetr was higher in the case group than in the control group at sampling sites 1 + 2 (p < 
0.0001) (Fig. 3 and 4), at sampling site 1 (p < 0.0001) and at sampling site 2 (p < 0.0001). 
The relative frequency was higher in farms that used water as liquid phase than in farms 
that mixed feed with whey at sampling sites 1 + 2 (p = 0.0295). The relative frequency did 
not differ between farms that cleaned their circuit pipeline after the group treatment and 
those that did not (p = 0.2371). 
 
The univariate logistic regression analysis identified the use of antimicrobials (OR = 30.0, 
CI 13.0 – 69.1, p < 0.001), sampling site 1 (OR = 2.2, CI 1.3 – 3.6, p = 0.002), the use of 
water (OR = 1.9, CI 1.1 – 3.4, p = 0.021) and the lack of acidification (OR = 4.1, CI 2.2 – 
7.6, p < 0.001) as risk factors for detecting Ent-Tetr in the sample with colony counts 
higher than 10 cfu/ml (Tab. 5). In the final multivariate logistic regression model, only the 
risk factors use of antimicrobials (OR = 58.9, CI 20.9 – 166.5, p < 0.001), sampling site 1 
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(OR = 5.4, CI 2.2 – 13.5, p < 0.001) and lack of acidification (OR = 4.9, CI 1.8 – 12.9, p = 
0.001) were left. The logistic regression analysis was also performed using only data from 
the case group. In the univariate logistic regression model, sampling site 1 (OR = 2.9, CI 
1.5 – 5.9, p = 0.003), lack of acidification (OR = 5.6, CI 2.5 – 12.3, p < 0.001) and use of 
an AMP with only chlortetracycline (OR = 3.1, CI 1.2 – 8.0, p = 0.019) could be identified 
as risk factors. In the final multivariate logistic regression model, only the risk factors 
sampling site 1 (OR = 4.3, CI 1.6 – 11.7, p = 0.004) and lack of acidification (OR = 6.3, CI 
2.2 – 18.3, p = 0.001) were left. 
 
The duration of the antimicrobial group treatment varied between 6 and 10 days (Tab. 1). If 
the criteria for a correct dosage (+/- 10%) described by Regula et al. (2009) is applied, then 
6 (46.2 %) farms applied a correct dosage, whereas 4 (30.8 %) and 3 (23.1 %) farms under- 
or overdosed, respectively. The daily dosage was applied in 5 (38.5 %) farms at 1 feeding 
in the morning, in 6 (46.2 %) farms at 2 feedings in the morning and afternoon or evening 
and in 2 (15.4 %) farms at 3 feedings. All case farms reduced the amount of liquid feed by 
a factor of 50 to 60 % by the time the pigs entered their farm and subsequently increased it 
to 100 % of the daily energy demand within a time span of eight to ten days. The daily 
applied amount of AMP stayed the same during the whole treatment period, which is the 
reason why the concentration of the antimicrobials in the liquid feed decreased from the 
start to the end of the antimicrobial group treatment (Tab. 1). Only 1 (7.7 %) and 4 (30.8 %) 
case farms cleaned their drop lines and circuit pipeline, respectively, after the antimicrobial 
medication. 12 (92.3 %) and 13 (100 %) case farms cleaned their circuit pipeline and drop 
lines, respectively, after the end of the fattening period. The cleaning of the drop lines was 
in all cases performed by means of cold or warm water and a high-pressure hose, which 
was inserted into the drop lines from their free end. There was 1 case farm that flushed its 
circuit pipeline only with water after the end of the fattening period and out of the 12 case 
farms that cleaned their circuit pipeline with some sort of agent, there was 1 farm that used 
a silage additive instead of a proper cleaning agent. In the control group, there were 4 (28.6 
%) and 6 (42.9 %) farms that have not cleaned their circuit pipelines and drop lines, 
respectively, for several years. 
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Discussion 
 
To the authors’ knowledge, this is the first report on the abundance of Ent-Tetr in the liquid 
feed for pigs as a function of the short-term use of in-feed antimicrobials. Our results 
suggest that feeding therapeutic doses of any of the three most frequently used 
antimicrobial combinations in Switzerland (Riklin, 2015) is the main risk factor for the 
presence of Ent-Tetr in the liquid feed. Other risk factors identified in this study encompass 
the lack of acidification of the liquid feed and the sampling of fluid feed from the end of the 
drop line. 
The selective pressure that is exerted by orally administered antimicrobials on the bacterial 
population in the liquid feed is reflected by the markedly higher proportion of feed samples 
containing Enterobacteriaceae resistant to tetracycline and by the higher number of cfu/ml 
of Ent-Tetr in the case group than in the control group. Antimicrobial resistant bacteria 
arise by mutations or by the acquisition of antimicrobial resistance determinants by HGT 
(Andersson and Hughes, 2011; Huddleston, 2014; van Schaik, 2015). It is well documented 
and widely accepted that the use of a given antimicrobial is the driving force behind the 
selection of bacteria resistant to the applied antimicrobial agent (Davies and Davies, 2010; 
Forslund et al., 2013; Modi et al. 2014). Interestingly, resistance to an antimicrobial can 
also be selected by the use of a structurally related (cross-selection) or unrelated (co-
selection) antimicrobial (Guardabassi and Kruse, 2008). The latter is the most probable 
explanation for our findings that there was no significant difference in the odds for 
resistance to tetracycline depending on whether or not the used AMP contained 
chlortetracycline. Resistance genes for trimethoprim-sulfametoxazole and tetracycline are 
reported to be often located on the same conjugative plasmid (Geser et al., 2012). Gibbons 
et al. (2015) identified the use of antimicrobial combinations containing sulphonamide and 
trimethoprim as a risk factor for the occurrence of E. coli resistant to tetracycline in the 
faeces of pigs. 
The application of antimicrobials via the liquid feeding system seems to be further 
associated with a quantitative shift in the population of Enterobacteriaceae from a 
predominantly tetracycline-susceptible towards a tetracycline-resistant population, which is 
reflected by the significantly higher relative frequency of Ent-Tetr in the liquid feed 
samples from case farms compared to those from control farms. These findings are in 
accordance with results from previous studies that link the use of antimicrobials with an 
increased frequency of ARB (Aminov, 2009; Andersson and Hughes, 2011). 
There are several beneficial effects of the addition of organic acids to pig feed. The main 
effect of dietary organic acids lies in the reduction of the pH in the stomach by lowering the 
acid buffering capacity of the feed, thus reducing the amount of commensals as well as 
pathogenic bacteria, e.g. Salmonella spp., in the swine gut (Suiryanrayna and Ramana, 
2015). While there was no significant difference in the pH between farms that used organic 
acids and those that did not (Tab. 4), the total number of Ent-Tetr as well as the number of 
samples containing Enterobacteriaceae resistant to tetracycline was significantly lower in 
samples from farms that added acids to the liquid feed (data not shown). Our data suggest 
that the use of organic acids is a protective factor for tetracycline resistance. As the case 
farms that applied acids were not the same as those that cleaned their circuit pipelines, the 
calculation of the corresponding odds ratios was not reciprocally influenced. 
All findings suggest a long-lasting effect of a repeated, short-term use of antimicrobials via 
the liquid feeding system on the abundance of Ent-Tetr in the liquid feed. However, the 
cleaning of the circuit pipeline after the medication in 4 case farms by means of a 
disinfectant was marked by a sharp decrease in the number of cfu/ml of Ent-Tetr at both 
sampling sites. As the sampling process was not continued in the following fattening 
period, it was not possible to determine whether the level of resistance in these 4 case farms 
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remained at a low level or whether the reservoir of resistance in the liquid feeding might 
have expanded between the two fattening periods, i.e. when the liquid feeding systems were 
not in operation. 
The median of the number of cfu/ml of Ent-Tetr was quite low at the end of the drop line 
(155 cfu/ml). However, it has to be considered that every fattening pig is fed, depending on 
its body weight, the energy content of the dry feed and fluid as well as the water to fluid 
ratio of the mixed liquid feed, a daily amount of 4 - 11 litre of liquid feed. Thus, it can be 
estimated, based on the quantitative assessment of tetracycline resistance in this study, that 
a fattening pig ingests approximately 6.2*10
5
 - 1.7*10
6
 Ent-Tetr every day. Looft et al. 
(2012) conducted a case-control study to investigate the effect of administering an in-feed 
antimicrobial combination (chlortetracycline, sulfamethazine, penicillin) over 14 days on 
the swine intestinal microbiome. They reported a significant shift in the composition of the 
bacterial community in the gut, e.g. a distinct proliferation of E. coli, and an increase in 
abundance and in diversity of AMR genes as a result of the antimicrobial treatment. 
This study has some limitations. Resistance to tetracycline was not determined in the 
individual components of the analysed liquid feed (water, whey, dry feed). It was therefore 
not possible to assess the proportion of ARB introduced from outside of the liquid feeding 
system. Cleaning routines and agents, as well as the use of organic acids were, purposely, 
not standardised. The authors’ intention was to assess the level of resistance to tetracycline 
in an average Swiss pig fattening farm and the chosen approach allowed to level out the 
substantial differences in the individual management routines among different farms. On 
the other hand, the robustness of the estimated risk factors could be impaired by this 
approach as it cannot be ruled out that not identified cofounders might have substantially 
influenced the results. 
We could identify medicated liquid feed as a potential source of ARB. Prophylactic 
antimicrobial group treatment in fattening pigs aims at preventing bacterial infections in 
periods of high risks such as after weaning, transport and mixing of animals from different 
farms (Schwarz et al., 2001; McEwen and Fedorka-Cray, 2002; Callens et al., 2012; 
Trauffler et al., 2014). The most frequently used antimicrobial agents used prophylactically 
in Swiss pig fattening farms (Riklin, 2015) are broad-spectrum antimicrobials and are 
classified as critically important (macrolides) or highly important (tetracyclines, 
sulphonamides and trimethoprim) for human medicine by the WHO Advisory Group on 
Integrated Surveillance of Antimicrobial Resistance (AGISAR) (Anonymous, 2012). As 
broad-spectrum antimicrobials are known to promote AMR (Barbosa and Levy, 2000), the 
guidelines for prudent use of veterinary drugs defined by the Swiss Veterinary Society 
(GST) (Brügger, 2010) advise veterinarians to use an antimicrobial with a spectrum as 
narrow as possible. It lies in the nature of prophylaxis that there is no specifically targeted 
microorganism and therefore complying with the guidelines is inherently not possible when 
using antimicrobials prophylactically. The national Strategy for Antibiotic Resistance 
(StAR) defines various measures in order to obtain its main goal, which is the preservation 
of efficacy of antimicrobial agents (Anonymous, 2015). One of the measures includes the 
revision of the above-mentioned guidelines and to declare them binding. It is further 
planned to introduce legally binding prescription limitations in veterinary medicine based 
on the categorisation by AGISAR (Anonymous, 2012) and to restrict the prophylactic 
antimicrobial use. The start of implementation of StAR was scheduled for 2016 and 
farmers as well as veterinarians are well advised to prepare for the far-reaching changes in 
pig production. However, the study by Riklin (2015) revealed that the prophylactic oral 
group treatment in Swiss fattening pigs was not associated with a lower overall mortality 
rate, a lower individual treatment frequency or an increased productivity. Hence, a 
profitable production of healthy swine seems to be realistic even under stricter legal 
regulations. 
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Table 2: Cleaning interval, cleaning agents and procedure (concentration, exposure time) of 
the 13 case and 14 control farms, * silage additive. 
 
Farm Cleaning interval Cleaning agent Procedure 
Case 1 After end of fattening period Vital: Venno-Vet 1 Super 1%, 15 minutes 
Case 2 
Every week and after end of 
fattening period  
Halag: Halades 01 0.5%, 12 hours 
Case 3 After end of fattening period Halag: Stallcip 666 3%, 0.5 - 1 hour 
Case 4 After end of fattening period  Amstutz: MILK-KLENE AD F 2%, 24 hours 
Case 5 
Every 10 days and after end of 
fattening period 
Selko: Anti-Entero plus 3%, 10.5 hours 
Case 6 After end of fattening period water rinsing 
Case 7 
After treatment and end of 
fattening period 
1. 3 - 4 kg barley grains 
2. Caustic soda 
 
1. Flushing the tubes with water 
containg barley 
2.  1%, 5 minutes 
Case 8 After end of fattening period Amstutz: MILK-KLENE AD F 2%, 24 - 48 hours 
Case 9 After end of fattening period Halag: Stallcip 666 2%, 20 - 25 minutes 
Case 10 After end of fattening period 
1. GEA Farm Technologies: 
CircoSuper AFM 
2. H2O2 
1. 3.7%, 30 minutes 
2. 0.5%, 4 hours 
Case 11 After end of fattening period Halag: Stallcip 666 2%, 30 minutes 
Case 12 After end of fattening period 
1. Halag: Halades 01 
2. Amstutz: MILK-KLENE AD 
F 
1. 3.5%, 48 hours 
2. 3.5%, 48 hours 
Case 13 
1. Every day 
2. After treatment and end of 
fattening period 
1. Halag: Halades 01 
2. Halag: Stallcip 666 
1. 0.5%, 12 hours 
2. 2%, 24 hours 
Control 1 Twice per year Vital: Venno-Vet 1 Super 1%, 30 minutes 
Control 2 Once per year Halag: Pasteurreiniger 405 2%, 30 minutes 
Control 3 No cleaning since 1987 
Control 4 Every 4 - 6 months Arkema: H2O2 (35%) 14%, 1 hour 
Control 5 No cleaning for at least 3 years 
Control 6 After end of fattening period Caustic soda 5.8%, 12 hours 
Control 7 Every 3 months 
GEA Farm Technologies: 
CircoPower AFM 
0.3%, 5 minutes 
Control 8 Once per week Alltech: Sil-All Fireguard * 0.8%, 12 hours 
Control 9 No cleaning since construction (15 years ago) 
Control 10 Every 2 weeks Halag: Halades 01 0.5 - 1%, 11 hours  
Control 11 Every 3 - 4 months Halag: Stallcip 666 2%, 30 - 40 minutes 
Control 12 Every 3 months Selko: Anti-Entero plus 
3 - 6 ‰, 12 hours, on 4 
consecutive days 
Control 13 No cleaning for at least 5 years 
Control 14 Every 3 months Selko: Anti-Hefen 0.5%, 10 hours 
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Table 3: Number of samples per sampling site, number of samples with at least 10 cfu/ml 
of Enterobacteriaceae or Enterobacteriaceae resistant to tetracycline (positive sample), 
mean, median and maximum of the observations, listed by group affiliation. 
 
  
Enterobacteriaceae Tetracycline-resistant Enterobacteriaceae 
Sampling site 
1 + 2 
Sampling 
site 1 
Sampling 
site 2 
Sampling site 
1 + 2 
Sampling 
site 1 
Sampling 
site 2 
Case group 
Samples  156 78 78 156 78 78 
Positive samples 
(%) 
119 (76.3) 68 (87.2) 51 (65.4) 104 (66.7) 61 (78.2) 43 (55.1) 
Mean [cfu/ml] 52'403.1 56'210.6 48'595.6 16’099.9 23’329.9 8’869.9 
Median [cfu/ml] 160 325 60 75 155 10 
Maximum [cfu/ml] 1'620'000 1'620'000 1'033'000 426’000 426’000 221’000 
Control group 
Samples  112 56 56 112 56 56 
Positive samples 
(%) 
63 (56.3) 35 (62.5) 28 (50.0) 7 (6.3) 7 (12.5) 0 (0) 
Mean [cfu/ml] 30'242.6 18'936.2 41'549.1 11.2 17.4 5 
Median [cfu/ml] 15 75 7.5 5 5 5 
Maximum [cfu/ml] 2'320'000 910'000 2'320'000 300 300 5 
! "#!
Table 4: Samples with at least 10 cfu/ml of Ent-Tetr (positive samples, grey shaded), listed by 
group affiliation, and number of positive samples at different sample times, listed by group 
affiliation. Clean = Cleaning of the circuit pipeline after the medication, Acid = Addition of 
organic acids to the liquid feed. 
 
Farm Sample Clean Acid 
Drop line 
[cfu/ml] 
Circuit pipeline 
[cfu/ml] 
 
Farm Sample Acid 
Drop line 
[cfu/ml] 
Circuit pipeline 
[cfu/ml] 
Case 1 
1  
YES 
19'500 
 
 
Control 1 
1 
YES 
  
2 50 60 
 
2 
  
3 740 700 
 
3 
  
4  
 
 
4 
  
5 20 10 
 
Control 2 
1 
YES 
  
6 100 490 
 
2 
  
Case 2 
1 
YES 
 5'560 9'500 
 
3 
  
2 
  
 
4 10 
 
 
3 
  
 
Control 3 
1    
4 
  
 
2 
  
5 70 
 
 
3 
  
6 190 90 
 
4 
  
Case 3 
1   230 0 
 
Control 4 
1 
YES 
  
2 35'800 58'000 
 
2 
  
3 6'300 1'100 
 
3 
  
4 11'000 2'000 
 
4 
  
5 9'800 10 
 
Control 5 
1 
YES 
  
6 7'500 890 
 
2 
  
Case 4 
1  
YES 
5'000 
 
 
3 
  
2  
 
 
4 
  
3  
 
 
Control 6 
1 
YES 
  
4  
 
 
2 
  
5  
 
 
3 70 
 
6  
 
 
4 
  
Case 5 
1 
YES 
 11'000 30 
 
Control 7 
1    
2 11'900 
 
 
2 
  
3 150 240 
 
3 
  
4 30 10 
 
4 20 
 
5 20 30 
 
Control 8 
1    
6 270 1'300 
 
2 300 
 
Case 6 
1   37'400 29'100 
 
3 
  
2 46'200 2'400 
 
4 30 
 
3 200 300 
 
Control 9 
1    
4 53'700 32'500 
 
2 
  
5 213'000 100'400 
 
3 
  
6 5'700 6'200 
 
4 
  
Case 7 
1 
YES 
 940  
 
Control 10 
1    
2 30 
 
 
2 
  
3 10 20 
 
3 
  
4 20 
 
 
4 
  
5 100 
 
 
Control 11 
1    
6 10 
 
 
2 
  
Case 8 
1   29'700 18'200 
 
3 
  
2 250'000 87'400 
 
4 
  
3 426'000 730 
 
Control 12 
1    
4 3'200 170 
 
2 
  
5 4'100 100 
 
3 
  
6 160 1'800 
 
4 
  
Case 9 
1   36'700 100'800 
 
Control 13 
1    
2 280 
 
 
2 
  
3 340 330 
 
3 
  
4 20 20 
 
4 
  
5 
  
 
Control 14 
1  270  
6 
  
 
2 30 
 
Case 10 
1   410'000 10 
 
3 
  
2 6'500 1'300 
 
4 
  
3 5'200 3'800 
 
Positive samples 7 (12.5 %) 0 (0 %) 
4 2'200 740 
 5 1'300 1'200 
 
Number of  samples 56 56 
6 50 90 
 
Case 11 
1   157'000 221'000 
   
 
  2 310 
 
 
Case group (n(ti) = 13; i = 1,...,6) 3 30 
 
 4 
  
 
Positive samples, t1 12 (92.3 %) 8 (61.5 %) 
5 520 1'270 
 6 80 30 
 
Positive samples, t2 10 (76.9 %) 6 (46.2 %) 
Case 12 
1  
YES 
  
 2 
  
 
Positive samples, t3 10 (76.9 %) 8 (61.5 %) 
3 30 
 
 4 110 
 
 
Positive samples, t4 9 (69.2 %) 6 (46.2 %) 
5 
  
 6 80 
 
 
Positive samples, t5 9 (69.2 %) 7 (53.8 %) 
Case 13 
1 
YES 
 3'100 7'300 
 2 80 10 
 
Positive samples, t6 11 (84.6 %) 8 (61.5 %) 
3 
  
 4 10 
 
   
 
  5 
  
 
Control group (n(ti) = 14; i = 1,...,4) 6 10 
  
 Positive samples 61 (78.2 %) 43 (55.1 %)  
 
Positive samples, t1 1 (7.1 %) 0 (0 %) 
Number of  samples 78 78  Positive samples, t2 2 (14.3 %) 0 (0 %) 
      Positive samples, t3 1 (7.1 %) 0 (0 %) 
      Positive samples, t4 3 (21.4 %) 0 (0 %) 
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Annotations to figures  
  
Figure 1: Boxplot of the number of cfu/ml of Ent-Tetr in the liquid feed of 13 case and 14 
control farms, collected at the end of the last drop line (sampling site 1) or at the end of the 
circuit pipeline (sampling site 2). 
 
Figure 2: Boxplot of the number of cfu/ml of Ent-Tetr in the liquid feed of 13 case farms at 6 
sample times and at sampling sites 1 + 2. 
 
Figure 3: Boxplot of the relative frequency of the number of cfu/ml of Ent-Tetr in the liquid 
feed of 13 case farms at 6 sample times and at sampling sites 1 + 2. 
 
Figure 4: Boxplot of the relative frequency of the number of cfu/ml of Ent-Tetr in the liquid 
feed of 14 control farms at 4 sample times and at sampling sites 1 + 2. 
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